SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,680 | -8.6% | 2,745 | -0.4% | 0.00% | 0.0% |
Q2 2023 | $82,815 | +68342.1% | 2,755 | -17.4% | 0.00% | 0.0% |
Q1 2023 | $121 | -0.8% | 3,335 | -2.6% | 0.00% | 0.0% |
Q4 2022 | $122 | -99.9% | 3,425 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $117,000 | +19.4% | 3,425 | +1.0% | 0.00% | 0.0% |
Q2 2022 | $98,000 | +15.3% | 3,390 | +28.4% | 0.00% | 0.0% |
Q1 2022 | $85,000 | -58.5% | 2,640 | -60.3% | 0.00% | -50.0% |
Q4 2021 | $205,000 | +101.0% | 6,643 | +73.0% | 0.00% | +100.0% |
Q3 2021 | $102,000 | -11.3% | 3,840 | +2.7% | 0.00% | 0.0% |
Q2 2021 | $115,000 | +27.8% | 3,740 | +8.4% | 0.00% | 0.0% |
Q1 2021 | $90,000 | +3.4% | 3,450 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $87,000 | +29.9% | 3,450 | +6.8% | 0.00% | 0.0% |
Q3 2020 | $67,000 | -88.9% | 3,230 | -87.3% | 0.00% | -83.3% |
Q2 2020 | $606,000 | +1453.8% | 25,527 | +1078.0% | 0.01% | – |
Q1 2020 | $39,000 | +5.4% | 2,167 | +38.3% | 0.00% | – |
Q4 2019 | $37,000 | -86.2% | 1,567 | -84.0% | 0.00% | -100.0% |
Q3 2019 | $268,000 | -11.8% | 9,770 | +6.5% | 0.00% | -33.3% |
Q2 2019 | $304,000 | -5.6% | 9,177 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $322,000 | +2827.3% | 9,177 | +2767.8% | 0.00% | – |
Q4 2018 | $11,000 | -31.2% | 320 | 0.0% | 0.00% | – |
Q3 2018 | $16,000 | -15.8% | 320 | 0.0% | 0.00% | – |
Q2 2018 | $19,000 | +26.7% | 320 | 0.0% | 0.00% | – |
Q1 2018 | $15,000 | 0.0% | 320 | -13.5% | 0.00% | – |
Q4 2017 | $15,000 | 0.0% | 370 | 0.0% | 0.00% | – |
Q3 2017 | $15,000 | -6.2% | 370 | 0.0% | 0.00% | – |
Q2 2017 | $16,000 | +33.3% | 370 | 0.0% | 0.00% | – |
Q1 2017 | $12,000 | -33.3% | 370 | -47.1% | 0.00% | – |
Q4 2016 | $18,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |